
A London hospital will investigate the use of a new drug that could help protect people with an impaired immune system from Covid-19.
The SUPERNOVA study will assess the efficacy of a monoclonal antibody drug named AZD3152.

A London hospital will investigate the use of a new drug that could help protect people with an impaired immune system from Covid-19.
The SUPERNOVA study will assess the efficacy of a monoclonal antibody drug named AZD3152.